Stephanie Curry

894 total citations
26 papers, 545 citations indexed

About

Stephanie Curry is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Stephanie Curry has authored 26 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 13 papers in Infectious Diseases and 13 papers in Epidemiology. Recurrent topics in Stephanie Curry's work include Hepatitis C virus research (15 papers), HIV/AIDS drug development and treatment (13 papers) and Hepatitis B Virus Studies (11 papers). Stephanie Curry is often cited by papers focused on Hepatitis C virus research (15 papers), HIV/AIDS drug development and treatment (13 papers) and Hepatitis B Virus Studies (11 papers). Stephanie Curry collaborates with scholars based in United States, Slovakia and United Kingdom. Stephanie Curry's co-authors include Cristiana Stellato, Patricia McMonagle, Ann‐Bin Shyu, Isabel López de Silanes, Myriam Gorospe, Ulus Atasoy, Ping Qiu, Vincenzo Casolaro, Xiao Tong and Robert A. Chase and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Blood.

In The Last Decade

Stephanie Curry

26 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephanie Curry United States	14	280	251	178	89	62	26	545
Domenico Criscuolo Italy	15	452 1.6×	495 2.0×	52 0.3×	88 1.0×	141 2.3×	42	918
Timothy Middleton United States	14	243 0.9×	377 1.5×	224 1.3×	173 1.9×	41 0.7×	28	829
Daniel Bradshaw United Kingdom	11	142 0.5×	202 0.8×	146 0.8×	81 0.9×	33 0.5×	28	505
Sun Suk Kim South Korea	8	306 1.1×	230 0.9×	46 0.3×	95 1.1×	78 1.3×	21	510
Axel Baumgarten Germany	19	718 2.6×	671 2.7×	571 3.2×	134 1.5×	39 0.6×	78	1.2k
Hugo Troonen Germany	10	199 0.7×	108 0.4×	108 0.6×	75 0.8×	21 0.3×	19	457
Peter Ackerman United States	11	142 0.5×	165 0.7×	232 1.3×	53 0.6×	12 0.2×	30	523
Paul Castellani France	13	423 1.5×	294 1.2×	41 0.2×	31 0.3×	20 0.3×	33	548
Wuping Li China	13	73 0.3×	153 0.6×	130 0.7×	128 1.4×	47 0.8×	35	485
R Chiesa Italy	12	368 1.3×	413 1.6×	33 0.2×	96 1.1×	31 0.5×	28	677

Countries citing papers authored by Stephanie Curry

Since Specialization

Citations

This map shows the geographic impact of Stephanie Curry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephanie Curry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephanie Curry more than expected).

Fields of papers citing papers by Stephanie Curry

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephanie Curry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephanie Curry. The network helps show where Stephanie Curry may publish in the future.

Co-authorship network of co-authors of Stephanie Curry

This figure shows the co-authorship network connecting the top 25 collaborators of Stephanie Curry. A scholar is included among the top collaborators of Stephanie Curry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephanie Curry. Stephanie Curry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Curry, Stephanie, Robin M. Kaufhold, Yuhua Zhang, et al.. (2022). Preclinical evaluation of an investigational 21-valent pneumococcal conjugate vaccine, V116, in adult-rhesus monkey, rabbit, and mouse models. Vaccine. 41(4). 903–913. 6 indexed citations

Asante‐Appiah, Ernest, Rong Liu, Stephanie Curry, et al.. (2018). In Vitro Antiviral Profile of Ruzasvir, a Potent and Pangenotype Inhibitor of Hepatitis C Virus NS5A. Antimicrobial Agents and Chemotherapy. 62(11). 4 indexed citations

Guo, Zhuyan, Stuart Black, Yuan Hu, et al.. (2017). Unraveling the structural basis of grazoprevir potency against clinically relevant substitutions in hepatitis C virus NS3/4A protease from genotype 1a. Journal of Biological Chemistry. 292(15). 6202–6212. 8 indexed citations

Asante‐Appiah, Ernest, Stephanie Curry, Patricia McMonagle, et al.. (2017). Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons. Antimicrobial Agents and Chemotherapy. 61(7). 19 indexed citations

Yu, Wensheng, Ling Tong, Bin Hu, et al.. (2016). Discovery of Chromane Containing Hepatitis C Virus (HCV) NS5A Inhibitors with Improved Potency against Resistance-Associated Variants. Journal of Medicinal Chemistry. 59(22). 10228–10243. 18 indexed citations

Asante‐Appiah, Ernest, William Marshall, Edward Gane, et al.. (2016). In a 5-Day Monotherapy Trial, MK-8408 Demonstrates Potent Antiviral Activity and Improved Resistance Profile in HCV Patients with Genotypes 1, 2, and 3 Infections. Journal of Hepatology. 64(2). S402–S402. 3 indexed citations

Howe, A, Stuart Black, Stephanie Curry, et al.. (2014). Virologic Resistance Analysis From a Phase 2 Study of MK-5172 Combined With Pegylated Interferon/Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 1 Infection. Clinical Infectious Diseases. 59(12). 1657–1665. 33 indexed citations

Kurniali, Peter C., et al.. (2014). A Retrospective Study Investigating the Incidence and Predisposing Factors of Hospital-Acquired Anemia. Anemia. 2014. 1–6. 28 indexed citations

Silva, Marcelo, Michelle Treitel, Donald J. Graham, et al.. (2013). Antiviral activity of boceprevir monotherapy in treatment-naive subjects with chronic hepatitis C genotype 2/3. Journal of Hepatology. 59(1). 31–37. 35 indexed citations

10.

Kurniali, Peter C., et al.. (2013). Incidence Of Hospital Acquired Anemia. Blood. 122(21). 1700–1700. 2 indexed citations

11.

Castillo, Jorge J., et al.. (2012). No association between cigarette smoking and incidence of plasma cell myeloma: A meta‐analysis of 17 observational studies. American Journal of Hematology. 87(7). 729–731. 7 indexed citations

12.

Black, Stuart, Patricia McMonagle, Robert A. Chase, et al.. (2012). 1198 HCV NS3/4A PROTEASE RESISTANCE-ASSOCIATED VARIANTS (RAVS) IDENTIFIED IN GENOTYPE 1A PATIENTS EXHIBIT DIFFERENCES IN PHENOTYPIC RESISTANCE TO BOCEPREVIR AND TELAPREVIR IN GENOTYPE 1A REPLICON CELLS. Journal of Hepatology. 56. S475–S475. 1 indexed citations

13.

Howe, John A., Donald J. Graham, Patricia McMonagle, et al.. (2012). 844 IN VITRO CHARACTERIZATION OF THE PAN-GENOTYPE ACTIVITY OF THE HCV NS3/4A PROTEASE INHIBITORS BOCEPREVIR AND TELAPREVIR. Journal of Hepatology. 56. S329–S329. 2 indexed citations

14.

Qiu, Ping, Stephanie Curry, Zhiyong Guo, et al.. (2009). Identification of HCV protease inhibitor resistance mutations by selection pressure-based method. Nucleic Acids Research. 37(10). e74–e74. 36 indexed citations

15.

Chase, Robert A., Angela Skelton, Ellen Xia, et al.. (2009). A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors. Antiviral Research. 84(2). 178–184. 14 indexed citations

16.

Curry, Stephanie, Ping Qiu, & Xiao Tong. (2008). Analysis of HCV resistance mutations during combination therapy with protease inhibitor boceprevir and PEG-IFN α-2b using TaqMan mismatch amplification mutation assay. Journal of Virological Methods. 153(2). 156–162. 27 indexed citations

17.

Beck, Lisa A., B. Tancowny, Mary Brummet, et al.. (2006). Functional Analysis of the Chemokine Receptor CCR3 on Airway Epithelial Cells. The Journal of Immunology. 177(5). 3344–3354. 42 indexed citations

18.

Atasoy, Ulus, Stephanie Curry, Isabel López de Silanes, et al.. (2003). Regulation of Eotaxin Gene Expression by TNF-α and IL-4 Through mRNA Stabilization: Involvement of the RNA-Binding Protein HuR. The Journal of Immunology. 171(8). 4369–4378. 106 indexed citations

19.

Stellato, Cristiana, et al.. (2003). Functional analysis of the chemokine receptor CCR3 on airway epithelial cells. Journal of Allergy and Clinical Immunology. 111(2). S148–S149. 2 indexed citations

20.

Heller, Nicola, Stephanie Curry, Renate Nickel, et al.. (2002). Post-transcriptional regulation of eotaxin by glucocorticoids (GC) and by interleukin (IL)-4. Journal of Allergy and Clinical Immunology. 109(1). S159–S159. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact